Last update 01 Nov 2024

Holopack Verpackungstechnik GmbH

Subsidiary Company|
1981|
Germany
|
www.holopack.de

Overview

Tags

Eye Diseases
Nervous System Diseases
Congenital Disorders
Small molecule drug
Recombinant protein
Chemical drugs

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Hemic and Lymphatic Diseases1
Nervous System Diseases1
Top 5 Drug TypeCount
Small molecule drug2
Recombinant protein1
Chemical drugs1
Top 5 TargetCount
ADRA2 x mAChRs1
mAChRs(Muscarinic acetylcholine receptor)1
TNF-α(Tumor necrosis factor α)1

Related

4
Drugs associated with Holopack Verpackungstechnik GmbH
Ferric Pyrophosphate Citrate
Target-
Mechanism
Fe modulators
Active Org.
Rockwell Medical, Inc.Rockwell Medical, Inc. [+2]
Originator Org.
Rockwell Medical, Inc.Rockwell Medical, Inc.
Active Indication
Chronic Kidney Diseases [+2]
Inactive Indication
Anemia, Iron-Deficiency [+3]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date23 Jan 2015
Aceclidine
Target
mAChRs
Mechanism
mAChRs agonists
Active Org.
Lenz Therapeutics, Inc.Lenz Therapeutics, Inc. [+2]
Originator Org.
Lenz Therapeutics, Inc.Lenz Therapeutics, Inc.
Active Indication
Presbyopia
Inactive Indication-
Drug Highest PhaseNDA/BLA
First Approval Ctry. / Loc.-
First Approval Date-
Aceclidine/Brimonidine
Target
ADRA2 x mAChRs
Mechanism
ADRA2 agonists [+1]
Active Org.
Lenz Therapeutics, Inc.Lenz Therapeutics, Inc. [+3]
Originator Org.
Lenz Therapeutics, Inc.Lenz Therapeutics, Inc.
Active Indication
Miosis [+2]
Inactive Indication-
Drug Highest PhasePhase 3
First Approval Ctry. / Loc.-
First Approval Date-
5
Clinical Trials associated with Holopack Verpackungstechnik GmbH
CTR20202142 / Active, not recruitingPhase 3
一项评价HBM9036（HL036）滴眼液（0.25%）与安慰剂相比治疗中国中、重度干眼患者的有效性和安全性的3期、多中心、随机、双盲、安慰剂对照研究
[Translation] A Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of HBM9036 (HL036) eye drops (0.25%) compared with placebo in the treatment of moderate to severe dry eye in Chinese patients
CTR20202200 / Active, not recruitingPhase 3
在中国CKD-5HD患者中通过血液透析液长期给予Triferic的随机、安慰剂对照研究。
[Translation] A randomized, placebo-controlled study of long-term administration of Triferic via hemodialysis fluid in Chinese patients with CKD-5HD.
CTR20182219 / CompletedPhase 2
评价HBM9036(HL036)滴眼液(0.25%)与安慰剂相比治疗中、重度干眼患者的有效性和安全性的II期、多中心、随机、双盲、安慰剂对照研究
[Translation] A Phase II, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of HBM9036 (HL036) eye drops (0.25%) compared with placebo in the treatment of patients with moderate to severe dry eye
100 Clinical Results associated with Holopack Verpackungstechnik GmbH
Login to view more data
0 Patents (Medical) associated with Holopack Verpackungstechnik GmbH
Login to view more data
2
Literatures (Medical) associated with Holopack Verpackungstechnik GmbH
Pharmazeutische Industrie
Validation of a production and distribution system for water for injection and purified water
Pharma Technologie Journal
Validation of a water treatment system for water for injection and purified water
100 Deals associated with Holopack Verpackungstechnik GmbH
Login to view more data
100 Translational Medicine associated with Holopack Verpackungstechnik GmbH
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1 Clinical
1
3
Phase 3 Clinical
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Tanfanercept
 ( TNF-α )		-
Phase 3
Aceclidine/Brimonidine
 ( ADRA2 x mAChRs )		Presbyopia
More
Phase 3
Ferric Pyrophosphate Citrate
Nephrosis
More
Phase 3
Aceclidine
 ( mAChRs )		Presbyopia
More
Phase 1
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free